Sean Brynjelsen, President & CEO at Eton Pharmaceuticals, Inc. (ETON), bought 10,000 shares at $7.96 ($79K) on 2019-05-21, disclosed to the SEC on 2019-05-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.78 | 1,400 | $11K | 13.7% |
| 2 | $7.96 | 8,600 | $68K | 86.3% |
| Total | $7.93 avg | 10,000 | $79K | 100% |
| Filing → |
| ETON | SELL | 2025-06-05 | $4.8M | — | Filing → |
| ETON | BUY | 2022-09-23 | $21K | — | Filing → |
| ETON | BUY | 2021-08-20 | $43K | — | Filing → |